You are currently browsing the archives for 1 November 2017.
Displaying 1 - 2 of 2 entries.

Diarrhoea with antibiotics can promote the pass on of drug-resistant super-bacteria.

Antibiotic use by travellers may promote spread of drug-resistant ‘super-bacteria’ Dealing with travellers' diarrhoea with antibiotics can promote the pass on of drug-resistant super-bacteria . Each full year, more than 300 million tourists visit with low standards of hygiene areas. A recently available Finnish study shows that about one-fifth of the travellers return home with an undesired companion, a drug-resistant intestinal bacterium. The chance of being contaminated with a drug-resistant intestinal bacterium raises significantly if the traveller evolves diarrhoea and particularly if he or she uses antibiotics to treat it, says Docent Anu Kantele of Helsinki University Central Hospital, an infectious disease expert who led the scholarly research published in the journal Clinical Infectious Diseases.

2007 and updated earnings assistance for the full year.

Bristol-Myers Squibb Company Reports Financial Results Bristol-Myers Squibb Business reported financial results for the 3rd quarter and nine a few months ended September 30, 2007 and updated earnings assistance for the full year. The business posted third quarter 2007 net sales of $5.1 billion, a rise of 22 percent over the same period in 2006 avodart generic . Bristol-Myers Squibb reported third one fourth 2007 net earnings of $858 million, or $0.43 per diluted share, under U.S. Generally Recognized Accounting Principles , in comparison to $338 million, or $0.17 per diluted talk about for the same period in 2006. The 2007 results add a one-time pre-taxes gain of $247 million ($144 million net of taxes, or $0.